+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Targeted Therapies"

Current Trends in Targeted Therapies in Non-Small Cell Lung Cancer (NSCLC) - Product Thumbnail Image

Current Trends in Targeted Therapies in Non-Small Cell Lung Cancer (NSCLC)

  • Report
  • April 2025
  • 15 Pages
  • Global
From
Innovation Insights: Engineered Exosomes - Product Thumbnail Image

Innovation Insights: Engineered Exosomes

  • Report
  • January 2025
  • 50 Pages
  • Global
From
Innovation Insights: siRNA gene silencing - Product Thumbnail Image

Innovation Insights: siRNA gene silencing

  • Report
  • January 2025
  • 53 Pages
  • Global
From
Structural Biology & Molecular Modeling Techniques Market by Tools, by Application, By End-User, and By Region - Product Thumbnail Image

Structural Biology & Molecular Modeling Techniques Market by Tools, by Application, By End-User, and By Region

  • Report
  • December 2024
  • 200 Pages
  • Global
From
Biopharmaceutical Market Outlook to 2029 - Product Thumbnail Image

Biopharmaceutical Market Outlook to 2029

  • Report
  • September 2024
  • 97 Pages
  • Global
From
Genomics Market Size and Forecasts 2020-2030: Global and Regional Share, Trends, and Growth Opportunity Analysis by Technology; Application; and End-User - Product Thumbnail Image

Genomics Market Size and Forecasts 2020-2030: Global and Regional Share, Trends, and Growth Opportunity Analysis by Technology; Application; and End-User

  • Report
  • August 2024
  • 116 Pages
  • Global
From
Genotyping Assay Market Size and Forecasts 2024-2034: Global and Regional Share, Trends, and Growth Opportunity Analysis by Technology; Application; and End-User - Product Thumbnail Image

Genotyping Assay Market Size and Forecasts 2024-2034: Global and Regional Share, Trends, and Growth Opportunity Analysis by Technology; Application; and End-User

  • Report
  • August 2024
  • 203 Pages
  • Global
From
IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition): Analysis By Antibody Source (Humanized, Fully Human, Chimeric, Other Sources), By Indication, By Region, By Country: Market Insights and Forecast (2019-2029) - Product Thumbnail Image

IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition): Analysis By Antibody Source (Humanized, Fully Human, Chimeric, Other Sources), By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)

  • Report
  • March 2024
  • 221 Pages
  • Global
From
USA Molecular Weight Marker Market Outlook to 2028 - Product Thumbnail Image

USA Molecular Weight Marker Market Outlook to 2028

  • Report
  • October 2023
  • 85 Pages
  • United States
From
Global DNA Sequencing Market 2030 by Product, Technology, Workflow, Application, End-Use and Region - Partner & Customer Ecosystem Competitive Index & Regional Footprints - Product Thumbnail Image

Global DNA Sequencing Market 2030 by Product, Technology, Workflow, Application, End-Use and Region - Partner & Customer Ecosystem Competitive Index & Regional Footprints

  • Report
  • August 2023
  • 180 Pages
  • Global
From
Precision and Personalized Medicine in Pharma - Thematic Intelligence - Product Thumbnail Image

Precision and Personalized Medicine in Pharma - Thematic Intelligence

  • Report
  • June 2023
  • 62 Pages
  • Global
From
Ovarian Cancer Cell and Gene Therapy Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast to 2031 - Product Thumbnail Image

Ovarian Cancer Cell and Gene Therapy Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast to 2031

  • Drug Pipelines
  • April 2023
  • 34 Pages
  • Global
From
Global Markets for Bioengineered Protein Drugs - Product Thumbnail Image

Global Markets for Bioengineered Protein Drugs

  • Report
  • March 2023
  • 185 Pages
  • Global
From
Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 83 Pages
  • Global
From
Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 83 Pages
  • Global
From
Hepatitis C Virus Envelope Protein E2 Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hepatitis C Virus Envelope Protein E2 Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 35 Pages
  • Global
From
Protein Tyrosine Phosphatase Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Protein Tyrosine Phosphatase Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 117 Pages
  • Global
From
Tumor Necrosis Factor Receptor Superfamily Member 4 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Tumor Necrosis Factor Receptor Superfamily Member 4 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 70 Pages
  • Global
From
Baculoviral IAP Repeat Containing Protein 5 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Baculoviral IAP Repeat Containing Protein 5 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 52 Pages
  • Global
From
Sphingosine 1-Phosphate Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Sphingosine 1-Phosphate Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 69 Pages
  • Global
From
Loading Indicator

The Targeted Therapies market within the context of Genomics is focused on the development of treatments that target specific genetic mutations or pathways. These therapies are designed to be more effective and have fewer side effects than traditional treatments. Genomics has enabled the development of personalized treatments that are tailored to the individual patient's genetic makeup. This has allowed for the development of drugs that target specific mutations or pathways, leading to more effective treatments. The Targeted Therapies market is a rapidly growing field, with many companies investing in research and development. Companies such as Gilead Sciences, Novartis, and AstraZeneca are leading the way in the development of targeted therapies. Other companies such as Merck, Pfizer, and Roche are also investing in the development of targeted therapies. Show Less Read more